Crystalvue Medical Corporation (TPEX:6527)
Taiwan
· Delayed Price · Currency is TWD 74.10
-1.40 (-1.85%)
Mar 10, 2026, 12:17 PM CST
Crystalvue Medical Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 132.02 | 241.64 | 273.35 | 176.55 | 193.78 | Upgrade
|
| Cash & Short-Term Investments | 132.02 | 241.64 | 273.35 | 176.55 | 193.78 | Upgrade
|
| Cash Growth | -45.37% | -11.60% | 54.83% | -8.89% | -57.25% | Upgrade
|
| Accounts Receivable | 243.95 | 187.09 | 124.24 | 160.79 | 110.37 | Upgrade
|
| Other Receivables | - | - | - | 1.9 | 0.03 | Upgrade
|
| Receivables | 243.95 | 187.09 | 124.24 | 162.69 | 110.4 | Upgrade
|
| Inventory | 253.69 | 260.1 | 286.2 | 257 | 195.83 | Upgrade
|
| Prepaid Expenses | 11.27 | 11.03 | 9.32 | 11.39 | 11.17 | Upgrade
|
| Other Current Assets | - | - | 3.01 | 2 | 7 | Upgrade
|
| Total Current Assets | 640.92 | 699.86 | 696.13 | 609.63 | 518.17 | Upgrade
|
| Property, Plant & Equipment | 638.71 | 470.12 | 366.51 | 390.23 | 408.07 | Upgrade
|
| Long-Term Investments | 3.6 | 3.6 | 3.6 | 3.97 | 3.38 | Upgrade
|
| Other Intangible Assets | 2.69 | 3.9 | 4.82 | 1.73 | 1.03 | Upgrade
|
| Long-Term Deferred Tax Assets | 4.34 | 2.47 | 2.01 | 1.81 | 2.16 | Upgrade
|
| Other Long-Term Assets | 5.02 | 4.95 | 5.36 | 5.62 | 5.7 | Upgrade
|
| Total Assets | 1,295 | 1,185 | 1,078 | 1,013 | 938.51 | Upgrade
|
| Accounts Payable | 89.85 | 90.26 | 69.2 | 68.75 | 52.19 | Upgrade
|
| Accrued Expenses | - | 47.4 | 38.02 | 35.25 | - | Upgrade
|
| Current Portion of Leases | 6.96 | 6.76 | 6.01 | 6.38 | 6.2 | Upgrade
|
| Current Income Taxes Payable | 31.05 | 25.15 | 31.2 | - | - | Upgrade
|
| Current Unearned Revenue | 3.33 | 16.86 | 15.23 | 13.76 | 12.45 | Upgrade
|
| Other Current Liabilities | 129.95 | 46.78 | 41.79 | 85.89 | 117.35 | Upgrade
|
| Total Current Liabilities | 261.14 | 233.22 | 201.45 | 210.03 | 188.19 | Upgrade
|
| Long-Term Leases | 4.75 | 11.7 | 19.02 | 25.03 | 31.41 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.91 | 1.47 | 0.9 | 2.26 | - | Upgrade
|
| Total Liabilities | 266.79 | 246.39 | 221.37 | 237.32 | 219.61 | Upgrade
|
| Common Stock | 254.59 | 254.59 | 254.59 | 242.76 | 242.76 | Upgrade
|
| Additional Paid-In Capital | 215.18 | 215.18 | 212.95 | 200.04 | 200.04 | Upgrade
|
| Retained Earnings | 572.28 | 482.32 | 407.46 | 372.85 | 304.12 | Upgrade
|
| Treasury Stock | -6.58 | -6.58 | -10.96 | -33.01 | -21.04 | Upgrade
|
| Comprehensive Income & Other | -6.97 | -6.97 | -6.97 | -6.97 | -6.97 | Upgrade
|
| Shareholders' Equity | 1,028 | 938.53 | 857.06 | 775.66 | 718.9 | Upgrade
|
| Total Liabilities & Equity | 1,295 | 1,185 | 1,078 | 1,013 | 938.51 | Upgrade
|
| Total Debt | 11.7 | 18.46 | 25.03 | 31.41 | 37.61 | Upgrade
|
| Net Cash (Debt) | 120.31 | 223.18 | 248.32 | 145.14 | 156.17 | Upgrade
|
| Net Cash Growth | -46.09% | -10.12% | 71.09% | -7.06% | -61.88% | Upgrade
|
| Net Cash Per Share | 4.67 | 8.69 | 9.82 | 5.69 | 6.16 | Upgrade
|
| Filing Date Shares Outstanding | 25.34 | 25.34 | 25.26 | 24.83 | 25.06 | Upgrade
|
| Total Common Shares Outstanding | 25.34 | 25.34 | 25.26 | 24.83 | 25.06 | Upgrade
|
| Working Capital | 379.79 | 466.65 | 494.68 | 399.6 | 329.98 | Upgrade
|
| Book Value Per Share | 40.59 | 37.03 | 33.92 | 31.23 | 28.69 | Upgrade
|
| Tangible Book Value | 1,026 | 934.63 | 852.24 | 773.93 | 717.87 | Upgrade
|
| Tangible Book Value Per Share | 40.48 | 36.88 | 33.73 | 31.16 | 28.65 | Upgrade
|
| Land | - | 312.35 | 312.35 | 312.35 | 312.35 | Upgrade
|
| Machinery | - | 271.32 | 140.93 | 136.91 | 129.43 | Upgrade
|
| Leasehold Improvements | - | 17.07 | 17.01 | 16.68 | 16.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.